- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05841212
DBT Skills Group for Adolescents With ADHD
The Acceptability and Feasibility of Implementing a Dialectical Behaviour Therapy (DBT) Skills Group for Adolescents With ADHD
Study Overview
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Diagnosis of Attention Deficit Hyperactive disorder (using either DSM 5, DSM-IV, or ICD-10 - F90)
- Age 13-16 years
- Likely to benefit from DBT skills and can safely access/ engage in group interventions as assessed by clinical team [for intervention part]
Exclusion criteria:
- A low enough proficiency in written and spoken English that they would be unable to engage in the content of the group.
- Have not recently changed their medication in the last 2 weeks*, commenced a new medication in the last 2 weeks* or are receiving additional concurrent psychological intervention. (*calculated from the start of the intervention).
- The identified participant has recently taken part in another research trial and are at risk of research burden.
- Pose a risk to others in the group
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: DBT for ADHD
The intervention will consist of a DBT skills group. Its name, length, style and content will be guided by the viewpoints shared in the intervention planning focus group/ individual interviews, and taken into consideration alongside a clinical rational and the evidence-based content. It will include skills from all four of the DBT modules: Mindfulness, Distress Tolerance, emotion regulation and interpersonal effectiveness. There will be an emphasis on the skills relevant to ADHD symptoms plus a core psychoeducational component on ADHD symptoms. The intervention will be adapted from Rathus and Miller's (2014) DBT for adolescents (DBT-A) manual. The group format will be didactic teaching with group discussion and experiential exercises to aid learning. |
See information included in arm/group description.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
25 participants with ADHD will be recruited from CAMHS services.
Time Frame: Within12-months
|
To assess whether the intervention is feasible in terms of recruitment, for adolescents with ADHD.
|
Within12-months
|
60% of participants or more will attend all group sessions.
Time Frame: Within12-months
|
To assess whether the intervention is feasible in terms of retention, for adolescents with ADHD.
|
Within12-months
|
60% or more of participants will complete a follow up measures.
Time Frame: Within12-months
|
To assess whether the intervention is feasible in terms of retention, for adolescents with ADHD.
|
Within12-months
|
Individual participant attendance rate will be greater than 50%.
Time Frame: Within12-months
|
To assess whether the intervention is feasible in terms of retention, for adolescents with ADHD.
|
Within12-months
|
66% of participants or more will report above neutral satisfaction ratings on weekly questionnaire
Time Frame: Within 12 months
|
To assess whether participants will find both the intervention and assessment methods acceptable.
|
Within 12 months
|
66% of participants or more from the focus group will report above neutral satisfaction.
Time Frame: Within 12 months
|
To assess whether participants will find both the intervention and assessment methods acceptable, we will conduct a focus group and use thematic analysis to ascertain the satisfaction rating.
|
Within 12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
At post-treatment compared to baseline participants will report improved levels of emotion regulation
Time Frame: Within 12 months
|
Participants will complete the DERS-SF (2015) pre and post the intervention.
We will report on any changes between baseline and post treatment score using effect sizes and confidence intervals.
As this is a pilot trial tentative conclusions will be drawn from these findings.
|
Within 12 months
|
At post-treatment compared to baseline participants will report a reduction in ADHD symptoms.
Time Frame: Within 12 months
|
Participants will complete the Connors 3rd edition self report form and SNAP-IV-26 (1992) pre and post the intervention.
We will report on any changes between baseline and post treatment score using effect sizes and confidence intervals.
As this is a pilot trial tentative conclusions will be drawn from these findings.
|
Within 12 months
|
At post treatment compared to baseline participants will report improved social skills and functioning.
Time Frame: Within 12 months
|
Participants will complete the WSAS-Y (2019) pre and post the intervention.
We will report on any changes between baseline and post treatment score using effect sizes and confidence intervals.
As this is a pilot trial tentative conclusions will be drawn from these findings.
|
Within 12 months
|
At post treatment compared to baseline participants will report improved social skills and functioning.
Time Frame: Within 12 months
|
Participants will complete the SDQ (2005) pre and post the intervention.
We will report on any changes between baseline and post treatment score using effect sizes and confidence intervals.
As this is a pilot trial tentative conclusions will be drawn from these findings.
|
Within 12 months
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- IRAS321708
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on ADHD
-
The Hong Kong Polytechnic UniversityRecruiting
-
University of North Carolina, Chapel HillNational Institute of Mental Health (NIMH)Recruiting
-
VIZO Specs LtdRecruiting
-
Loewenstein HospitalWingate InstituteRecruiting
-
Florida State UniversityRecruiting
-
Florida International UniversityRecruiting
-
Region Örebro CountyRecruiting
-
Johns Hopkins UniversityWithdrawn
-
Tris Pharma, Inc.Premier Research Group plcCompleted
Clinical Trials on DBT for ADHD
-
Radboud University Medical CenterZonMw: The Netherlands Organisation for Health Research and DevelopmentCompleted
-
Universitaire Ziekenhuizen KU LeuvenKU Leuven; Research Foundation FlandersActive, not recruiting
-
Haukeland University HospitalRecruitingSuicidal Ideation | Self-harm | Suicide and Self-harmNorway
-
Dalhousie UniversityCompletedAttention Deficit Hyperactivity Disorder (ADHD)Canada
-
University of IcelandActive, not recruitingAttention-deficit HyperactivityIceland
-
Children's Hospital Medical Center, CincinnatiCompletedAttention Deficit Hyperactivity DisorderUnited States
-
University of BergenHaukeland University HospitalRecruitingAttention Deficit Hyperactivity DisorderNorway
-
Oslo University HospitalLovisenberg Diakonale HospitalUnknownAttention Deficit Hyperactivity Disorder | Disruptive Mood Dysregulation DisorderNorway
-
Children's Hospital of PhiladelphiaCompletedAttention Deficit Hyperactivity DisorderUnited States
-
Children's Hospital Medical Center, CincinnatiNational Institute of Mental Health (NIMH)CompletedAttention Deficit Hyperactivity Disorder | Adherence, MedicationUnited States